Do you really need investors to scale?

There is no universal answer. Plenty of B2B SaaS companies have scaled cleanly without ever taking external capital. Plenty of others have raised too late and paid the dilution cost of a weaker position. Three structural tests separate the two, and they are worth running before the urgency to raise pushes the question off the table.

Test one: capital intensity of the business model

Some software businesses are structurally capital-light. The product cycle is short, the customer acquisition cycle is short, and the gross-margin profile is high enough that growth can be funded from operating cash flow. Vertical SaaS with strong NRR, productivity tooling with a self-serve motion, developer tooling with bottoms-up adoption - these models can compound on retained earnings if the founder is willing to grow at the rate retained earnings allow.

Other software businesses are structurally capital-intensive. Enterprise SaaS with a 9–12 month sales cycle, AI-native products that depend on continuous inference spend, regulated-industry software with a long procurement cycle - the working-capital and infrastructure cost of getting to the next milestone exceeds the cash flow available, and external capital is the structural answer.

The first test is therefore: is the capital intensity of the business model genuinely high, or are we using external capital to compress a timeline that retained earnings could otherwise fund?

Test two: competitive dynamics in the market

If the market is structurally winner-take-most - a single dominant vendor will end up with 60–80% of the value - the cost of growing slowly is asymmetrically high. Capital is the way to compress the time-to-market and the time-to-scale in markets where the second-place vendor ends up with a significantly weaker franchise.

If the market is structurally fragmentable - the first dozen vendors all end up with meaningful franchises - the cost of growing slowly is much lower. A capital-light operator can carve out a defensible position by going deeper in a narrower segment, and the dilution cost of raising for speed is no longer obviously worth paying.

The second test is: does the competitive structure of this market reward speed enough to justify the dilution cost of an external round?

Test three: the binding constraint at the next milestone

This is the test we think founders run least often and that matters most. The next 18–24 months have a binding constraint - one thing that will most determine whether the company hits its plan. Sometimes that constraint is capital: there is a known commercial bet that requires funding that retained earnings can’t produce on time. More often the constraint is something else - execution capacity, senior commercial leadership, engineering throughput, governance maturity, geographic operating depth.

If the constraint is capital, an external round directly addresses it. If the constraint is something else, capital is at best indirect. The company raises the round, but the proceeds do not solve the binding constraint - they fund hiring people who then take six quarters to ramp, while the constraint remains operationally live.

This is the structural argument for operator-led growth equity over capital-only growth equity. When the binding constraint is execution capacity rather than capital, the right instrument is capital paired with deployed operating people who address the constraint directly - not capital alone hoping the founder can hire fast enough to convert it.

What changes if the honest answer is “yes, we should raise”

If the three tests resolve as “genuinely capital-intensive model, winner-take-most market, capital is the binding constraint” - the question shifts from should we raise to what is the right shape of capital. The major options:

Venture capital. Equity at the highest dilution cost, with the upside of pattern-matching networks and a power-law return expectation that aligns with aggressive growth.
Growth equity, capital-only. Minority equity, less dilutive than venture but typically with less operating involvement - advisory rather than embedded.
Operator-led growth equity. Minority equity paired with embedded operating capacity - the structural fit if execution capacity is part of the binding constraint, even partially.
Strategic capital. A corporate strategic with sector adjacency - useful in specific structures, complicated by commercial-conflict considerations.
Revenue-based financing. Non-dilutive, structured around revenue stream - useful for capital-light models with predictable recurring revenue, less useful for capital-intensive ones.

The decision in each case depends on the binding constraint the company is actually trying to address - not on which instrument is in fashion.

The honest answer for most founders

Most founders we engage with answer the three tests this way: capital intensity is moderate; competitive structure is fragmentable enough that being second isn’t fatal; the binding constraint is execution capacity rather than capital. For founders in that profile, the structural fit is operator-paired capital rather than capital-only capital - the dilution buys deployed operating people, not just optionality. Founders for whom that profile fits should consider that route rather than defaulting to a capital-only round on the assumption that there isn’t a better instrument.